GENTA INCORPORATED /DE/
4/A, 1998-11-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENTA INCORPORATED /DE/, 4/A, 1998-11-12
Next: GENTA INCORPORATED /DE/, 4/A, 1998-11-12



                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                     FORM 4

                  STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

( ) Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).

1. Name and Address of Reporting Person

   Rosenwald, Lindsay A.
   787 Seventh Avenue
   48th Floor
   New York, NY  10019

2. Issuer Name and Ticker or Trading Symbol

   Genta Incorporated
   GNTA

3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year

   DECEMBER/1997

5. If Amendment, Date of Original (Month/Year)

   01/09/98

6. Relationship of Reporting Person(s) to Issuer (Check all applicable)

   ( ) Director (X) 10% Owner ( ) Officer (give title below) ( ) Other
   (specify below)
   
7. Individual or Joint/Group Filing (Check Applicable Line)

   ( ) Form filed by One Reporting Person
   (X) Form filed by More than One Reporting Person
<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.    |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect       |
                           | Transaction |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership     |
                           |      |      |                                  |  Beneficially     |(D)or |                           |
                           |      |    | |                  | A/|           |  Owned at         |Indir |                           |
                           | Date |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                           |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
___________________________________________________________________________________________________________________________________|


<PAGE>


<CAPTION>
___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |           | A/|Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | |           | D |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|  Amount   |   |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Series D Convertible  |$0.94375|12/29|J(1)| |16,158(3)  |D   |12/31|N/A  |Common Stock|1,712,1|   (3) |(1)(2)      |D  |           |
Preferred Stock(1)    |        |/97  |(3) | |           |    |/97  |     |            |06     |       |            |   |           |
                      |        |     |(4) | |           |    |     |     |            |       |       |            |   |           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants(1)   |$0.94375|12/29|J(1)| |80,790(3)  |D   |12/31|6/30/|Common Stock|80,790 |   (3) |(1)(2)      |D  |           |
                      |        |/97  |(3) | |           |    |/97  |02   |            |       |       |            |   |           |
                      |        |     |(4) | |           |    |     |     |            |       |       |            |   |           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Series D Convertible  |$0.94375|12/29|J(1)| |7,412(4)   |A   |12/31|N/A  |Common Stock|785,429|   (4) |(1)(2)      |D  |           |
Preferred Stock(1)    |        |/97  |(3) | |           |    |/97  |     |            |       |       |            |   |           |
                      |        |     |(4) | |           |    |     |     |            |       |       |            |   |           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants(1)   |$0.94375|12/29|J(1)| |37,062(4)  |A   |12/31|6/30/|Common Stock|37,062 |   (4) |(1)(2)      |D  |           |
                      |        |/97  |(3) | |           |    |/97  |02   |            |       |       |            |   |           |
                      |        |     |(4) | |           |    |     |     |            |       |       |            |   |           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Series D Convertible P|$0.94375|12/29|J(1)| |24,237(3)  |A   |12/31|N/A  |Common Stock|2,568,1|   (3) |(1)(2)      |D  |           |
referred Stock(2)     |        |/97  |(3) | |           |    |/98  |     |            |59     |       |            |   |           |
                      |        |     |(4) | |           |    |     |     |            |       |       |            |   |           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants(2)   |$0.94375|12/29|J(1)| |121,185(3) |A   |12/31|6/30/|Common Stock|121,185|   (3) |(1)(2)      |D  |           |
                      |        |/97  |(3) | |           |    |/98  |02   |            |       |       |            |   |           |
                      |        |     |(4) | |           |    |     |     |            |       |       |            |   |           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Series D Convertible  |$0.94375|12/29|J(2)| | 18,420(4) |D   |12/31|N/A  |Common Stock|1,951,8|(4)    |(1)(2)      |D  |           |
Preferred Stock (2)   |        |/97  |(3) | |           |    |/98  |     |            |01     |       |            |   |           |
                      |        |     |(4) | |           |    |     |     |            |       |       |            |   |           |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants(2)   |$0.94375|12/29|J(2)| | 92,101(4) |D   |12/31|6/30/|Common Stock| 92,101|   (4) |(1)(2)      |D  |           |
                      |        |/97  |(3) | |           |    |/98  |02   |            |       |       |            |   |           |
                      |        |     |(4) | |           |    |     |     |            |       |       |            |   |           |
____________________________________________________________________________________________________________________________________
</TABLE>
Explanation of Responses:

See Attachment A.

(1)  These Series D Preferred Stock and Class D Warrants are components of units
     ("Units")  issuable  upon  exercise  of  warrants  ("Placement   Warrants")
     exercisable  from  December 31, 1997 to December  30,  2007,  at an initial
     exercise price of $110,000 per Unit. Each Unit consists,  initially, of (i)
     1,000  shares of Series D Preferred  Stock of the Issuer,  par value $0.001
     per share,  and (ii) 5,000 Class D Warrants.  Lindsay A. Rosenwald,  may be
     deemed  beneficially  to own, and  Paramount  Capital Inc. may be deemed to
     have disposed of beneficial ownership of, Placement Warrants to purchase an
     aggregate of 7.41249 and 16.158 Units, respectively. The Placement Warrants
     contain certain anti- dilution adjustments.
(2)  These Series D Preferred Stock and Class D Warrants are components of Units
     issuable upon exercise of warrants ("Advisory  Warrants")  exercisable from
     December  31, 1998 to December 30, 2007,  at an initial  exercise  price of
     $110,000 per Unit. Lindsay A. Rosenwald, may be deemed beneficially to own,
     and  Paramount  Capital Inc. may be deemed to have  disposed of  beneficial
     ownership  of,  Advisory  Warrants to purchase an aggregate of 18.42012 and
     24.237  Units,   respectively.   The  Advisory   Warrants  contain  certain
     anti-dilution adjustments.
(3)  On December 29, 1997,  Paramount  Capital Inc.  designated  recipients (the
     "Paramount  Warrant  Designees") of the Placement Warrants and the Advisory
     Warrants.
(4)  Dr. Rosenwald was among the Paramount  Warrant  Designees and received such
     Placement  Warrants  and  Advisory  Warrants in  connection  with a private
     placement of  securities  of the Issuer of which  Paramount  Capital,  Inc.
     acted as placement agent.


SIGNATURE OF REPORTING PERSON
/s/Lindsay A. Rosenwald, M.D.
- ---------------------------------
Lindsay A. Rosenwald, M.D., 
Individually, and as President of
Paramount Capital, Inc.
DATE
11/12/98

<PAGE>

                                  Attachment A


     Reporting Persons:   Lindsay A. Rosenwald, M.D. (the designated filer); and
                          Paramount Capital, Inc.
                          787 Seventh Avenue, 48th Floor
                          New York, NY 10019

     Issuer:              Genta Incorporated (GNTA)

     Statement For:       December / 1997

     Lindsay A.  Rosenwald,  M.D.,  the  President and sole  shareholder  of
Paramount Capital, Inc., is also the President and sole shareholder of Paramount
Capital Asset Management,  Inc. ("Paramount").  Paramount is the General Partner
of the Aries  Domestic  Fund,  L.P. (the  "Partnership")  and also serves as the
Investment Manager to The Aries Trust (the "Trust"), a Cayman Islands trust. The
Partnership  and the Trust each owns  securities  of the Issuer.  The  Reporting
Persons disclaim beneficial  ownership of the securities held by the Partnership
and the Trust, except to the extent of their pecuniary interest therein, if any.

     Paramount   Capital,   Inc.  is  no longer   subject  to  Section 16 of the
Securities Exchange Act of 1934, as amended.



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission